IL10 and Hepatitis: These results indicate that both increased inflammatory costimulatory proteins and decreased inhibitory costimulatory proteins participated in hepatitis activation in ACH patients, and that inhibitory costimulatory proteins CTLA-4 and IL-10 contributed to immune tolerance and maintained normal hepatic function in ACs.